Ryan Charles S. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Ryan Charles S. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Charles S. Ryan serves as President of Quince Therapeutics, Inc. (QNCX). In the most recent SEC filing dated January 24, 2026, he is listed as an insider with no reported purchases or sales. Quince Therapeutics is a preclinical biopharmaceutical company focused on precision therapeutics for rare diseases, including a bone-targeting drug delivery platform aimed at promoting rapid healing with targeted delivery.
Role
Insider
Notability
42/100
Board memberships
Quince Therapeutics, Inc.
Awards & honors
President of Quince Therapeutics, Inc.
Insider status in SEC filing dated January 24, 2026
Frequently Asked Questions
Who is Ryan Charles S.?
Charles S. Ryan serves as President of Quince Therapeutics, Inc. (QNCX). In the most recent SEC filing dated January 24, 2026, he is listed as an insider with no reported purchases or sales. Quince Therapeutics is a preclinical biopharmaceutical company focused on precision therapeutics for rare diseases, including a bone-targeting drug delivery platform aimed at promoting rapi…
Where can I see all of Ryan Charles S.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
